[en] Histopathological studies of gastrointestinal motility disorders have mainly focused on enteric nerves and interstitial cells of Cajal, but rarely considered the enteric musculature. Here we used both classical and novel smooth muscle markers and transmission electron microscopy (TEM) to investigate muscular alterations in severe colorectal motility disorders. Full-thickness specimens from Hirschsprung's disease, idiopathic megacolon, slow-transit constipation and controls were stained with haematoxylin/eosin (HE) and Masson's trichrome (MT), incubated with antibodies against smooth muscle alpha-actin (alpha-SMA), smooth muscle myosin heavy chain (SMMHC), smoothelin (SM) and histone deacetylase 8 (HDAC8) and processed for TEM. Control specimens exhibited homogeneous immunoreactivity for all antibodies. Diseased specimens showed normal smooth muscle morphology by HE and MT. While anti-alpha-SMA staining was generally normal, immunoreactivity for SMMHC, HDAC8 and/or SM was either absent or focally lacking in Hirschsprung's disease (80%), idiopathic megacolon (75%) and slow-transit constipation (70%). Ultrastructurally, clusters of myocytes with noticeably decreased myofilaments were observed in all diseases. SMMHC and the novel smooth muscle markers SM and HDAC8 often display striking abnormalities linked to the smooth muscle contractile apparatus unnoticed by both routine stainings and alpha-SMA, suggesting specific defects of smooth muscle cells involved in the pathogenesis of gastrointestinal motility disorders.
Schemann M Neunlist M. The human enteric nervous system. Neurogastroenterol Motil 2004 16 Suppl. 1 55 9.
De Giorgio R Guerrini S Barbara G Cremon C Stanghellini V Corinaldesi R. New insights into human enteric neuropathies. Neurogastroenterol Motil 2004 16 Suppl. 1 143 7.
Rumessen JJ Vanderwinden JM. Interstitial cells in the musculature of the gastrointestinal tract: Cajal and beyond. Int Rev Cytol 2003 229: 115 208.
Schuffler MD Lowe MC Bill AH. Studies of idiopathic intestinal pseudoobstruction. I. Hereditary hollow visceral myopathy: clinical and pathological studies. Gastroenterology 1977 73: 327 38.
Mitros FA Schuffler MD Teja K Anuras S. Pathologic features of familial visceral myopathy. Hum Pathol 1982 13: 825 33.
Alstead EM Murphy MN Flanagan AM Bishop AE Hodgson HJ. Familial autonomic visceral myopathy with degeneration of muscularis mucosae. J Clin Pathol 1988 41: 424 9.
Moore SW Schneider JW Kaschula RO. Unusual variations of gastrointestinal smooth muscle abnormalities associated with chronic intestinal pseudo-obstruction. Pediatr Surg Int 2002 18: 13 20.
Fitzgibbons PL Chandrasoma PT. Familial visceral myopathy. Evidence of diffuse involvement of intestinal smooth muscle. Am J Surg Pathol 1987 11: 846 54.
Gattuso JM Kamm MA Talbot JC. Pathology of idiopathic megarectum and megacolon. Gut 1997 41: 252 7.
Cheng W Lui VC Chen QM Tam PK. Enteric nervous system, interstitial cells of Cajal, and smooth muscle vacuolization in segmental dilatation of jejunum. J Pediatr Surg 2001 36: 930 5.
Ruuska TH Karikoski R Smith VV Milla PJ. Acquired myopathic intestinal pseudo-obstruction may be due to autoimmune enteric leiomyositis. Gastroenterology 2002 122: 1133 9.
Nezelof C Vivien E Bigel P et al. [Idiopathic myositis of the small intestine. An unusual cause of chronic intestinal pseudo-obstruction in children]. Arch Fr Pediatr 1985 42: 823 8.
Ginies JL Francois H Joseph MG Champion G Coupris L Limal JM. A curable cause of chronic idiopathic intestinal pseudo-obstruction in children: idiopathic myositis of the small intestine. J Pediatr Gastroenterol Nutr 1996 23: 426 9.
Smith VV Milla PJ. Histological phenotypes of enteric smooth muscle disease causing functional intestinal obstruction in childhood. Histopathology 1997 31: 112 22.
Knowles CH Silk DB Darzi A et al. Deranged smooth muscle alpha-actin as a biomarker of intestinal pseudo-obstruction: a controlled multinational case series. Gut 2004 53: 1583 9.
Skalli O Ropraz P Trzeciak A Benzonana G Gillessen D Gabbiani G. A monoclonal antibody against alpha-smooth muscle actin: a new probe for smooth muscle differentiation. J Cell Biol 1986 103: 2787 96.
van der Loop FT Schaart G Timmer ED Ramaekers FC van Eys GJ. Smoothelin, a novel cytoskeletal protein specific for smooth muscle cells. J Cell Biol 1996 134: 401 11.
Rensen SS Thijssen VL De Vries CJ Doevendans PA Detera-Wadleigh SD van Eys GJ. Expression of the smoothelin gene is mediated by alternative promoters. Cardiovasc Res 2002 55: 850 63.
Christen T Verin V Bochaton-Piallat M et al. Mechanisms of neointima formation and remodeling in the porcine coronary artery. Circulation 2001 103: 882 8.
Maeng M Mertz H Nielsen S van Eys GJ Rasmussen K Espersen GT. Adventitial myofibroblasts play no major role in neointima formation after angioplasty. Scand Cardiovasc J 2003 37: 34 42.
de Ruijter AJ van Gennip AH Caron HN Kemp S van Kuilenburg AB. Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem J 2003 370: 737 49.
Luo J Nikolaev AY Imai S et al. Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell 2001 107: 137 48.
Hubbert C Guardiola A Shao R et al. HDAC6 is a microtubule-associated deacetylase. Nature 2002 417: 455 8.
North BJ Marshall BL Borra MT Denu JM Verdin E. The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase. Mol Cell 2003 11: 437 44.
Waltregny D De LL Glenisson W et al. Expression of histone deacetylase 8, a class I histone deacetylase, is restricted to cells showing smooth muscle differentiation in normal human tissues. Am J Pathol 2004 165: 553 64.
Waltregny D Glénisson W Tran SL et al. Histone deacetylase HDAC8 associates with smooth muscle a-actin and is essential for smooth muscle cell contractility. FASEB J 2005 19: 966 8.
Vanderwinden JM Rumessen JJ Liu H Descamps D De Laet MH Vanderhaeghen JJ. Interstitial cells of Cajal in human colon and in Hirschsprung's disease. Gastroenterology 1996 111: 901 10.
Wedel T Spiegler J Soellner S et al. Enteric nerves and interstitial cells of Cajal are altered in patients with slow-transit constipation and megacolon. Gastroenterology 2002 123: 1459 67.
Wedel T Roblick UJ Ott V et al. Oligoneuronal hypoganglionosis in patients with idiopathic slow-transit constipation. Dis Colon Rectum 2002 45: 54 62.
Babu GJ Warshaw DM Periasamy M. Smooth muscle myosin heavy chain isoforms and their role in muscle physiology. Microsc Res Tech 2000 50: 532 40.
Jarrousse C Lods N Michel F Bali JP Magous R. Cultured gastrointestinal smooth muscle cells: cell response to contractile agonists depends on their phenotypic state. Cell Tissue Res 2004 316: 221 32.
Niessen P Clement S Fontao L et al. Biochemical evidence for interaction between smoothelin and filamentous actin. Exp Cell Res 2004 292: 170 8.
Niessen P Rensen S van Deursen J et al. Smoothelin-A is essential for functional intestinal smooth muscle contractility in mice. Gastroenterology 2005 129 (5): 1592 601.
Gamba E Carr NJ Bateman AC. Deficient alpha smooth muscle actin expression as a cause of intestinal pseudo-obstruction: fact or fiction J Clin Pathol 2004 57: 1168 71.
Fromont-Hankard G Lafer D Masood S. Altered expression of alpha-smooth muscle isoactin in Hirschsprung's disease. Arch Pathol Lab Med 1996 120: 270 4.
Lofgren M Fagher K Wede OK Arner A. Decreased shortening velocity and altered myosin isoforms in guinea-pig hypertrophic intestinal smooth muscle. J Physiol 2002 544: 707 14.
Mannikarottu AS Hypolite JA Zderic SA Wein AJ Chacko S Disanto ME. Regional alterations in the expression of smooth muscle myosin isoforms in response to partial bladder outlet obstruction. J Urol 2005 173: 302 8.
